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The concepts of child and adolescent psychiatric disorders
show both continuity and change. Whereas the main broad
psychopathological phenomena do not change fundamen-
tally, there is an ongoing process of refining diagnostic
criteria of various disorders, delineating new subtypes, and,
from time to time, also the definition of a new diagnostic
entity. These processes are reflected in the major classifi-
cation systems forming an important framework of clinical
work and service delivery which are existing now already
for several decades. Another important cornerstone struc-
turing clinical practice is the increasing number of disor-
der-specific guidelines for both assessment and treatment
of these disorders.
Currently, the revision of the two major international
classification systems, the US-American Diagnostic and
Statistical Manual of Mental Disorders, fifth revision
(DSM-5) and the International Classification of Diseases,
11th revision are in a relatively advanced stage of devel-
opment with the DSM-5 expected to be published in May
2013 and the ICD-11 2 years later in 2015. Irrespective of
the evaluation whether the upcoming changes in these
classification of child and adolescent disorders are mainly
driven by research findings or by political or even financial
interests, it is clear that these revisions will have a strong
impact on the understanding of these disorders both in
clinical care and research.
Thus, it is time to make clinicians and service providers
acquainted with the current status of the upcoming changes
in the classification of the major mental disorders in chil-
dren and adolescents. Currently, there is much more infor-
mation available on the upcoming changes in the DSM than
in the ICD. However, the cross-talk between the two sys-
tems, certainly, will have a strong impact for the 11th
revision of the ICD. In the first part, the chapters on the
various disorders concentrate on the question what kind of
changes we will have to expect in the DSM-5 and what kind
of impact these changes will have for clinical practice.
The present collection of papers is restricted to the major
mental disorders in childhood and adolescence. Many of
them continue into adulthood and could be regarded as a
specific manifestation at a young age so that one may indeed
argue that a separate grouping as disorders with an onset
specific to childhood could be deleted from the upcoming
revised classifications. This pertains, e.g., for the schizo-
phrenic psychoses, the affective disorders, the anxiety dis-
orders, and the obsessive–compulsive disorders.
However, other disorders have a rather characteristic
onset early in life. They include the infant psychiatric
disorders, the autism spectrum disorders, and the elimina-
tion disorders which are discussed in the present supple-
ment. All of these disorders will either show full remission
in childhood or only minor or moderate transformations of
symptoms but lasting effects on psychosocial functioning
for the entire life like the autism spectrum disorders. In the
DSM-5, some of these disorders will be reclassified as
neurodevelopmental disorders including also the very
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common attention-deficit–hyperactivity disorders, or as a
separate category like the elimination disorders. Similarly,
another very common disorder in childhood and adoles-
cence, namely, conduct disorder will also be reclassified in
a new category of disruptive, impulse control, and conduct
disorders rather than keeping it within a group of disorders
with onset in infancy, childhood, and adolescence. Fur-
thermore, revised classifications may include candidates of
new disorders with a known clinical manifestation but
perhaps still lacking sufficient proof of validity. Currently,
the non-suicidal self-injury is such a new disorder in DSM-
5 which, however, is only listed in a final class with the
unspecific name of ‘‘Other disorders’’.
In addition to introducing the upcoming changes in DSM-
5, each chapter of the present supplement includes a brief
review of the impact of clinical guidelines for the various
disorders. The main aim of clinical guidelines is to assure
high-quality assessment and to make the most advanced
treatment options available to the patient. According to the
British National Institute of Health and Clinical Excellence
(NICE) in the National Health System, recommendations are
based on the best available empirical evidence, include the
views of experts, patients and carers, are developed by
independent and unbiased advisory committees, are staying
up-to-date by regular reviews, are based on an open and
transparent consultation process, and value the input of
patients, carers and the general public.
In the recent past, there has been an increasing trend in
international child and adolescent psychiatry to design and
publish guidelines for a large variety of clinical disorders
and problems. Again, this process is most advanced in the
USA with a substantial number of practice parameters
authored by expert committees and edited by the American
Academy of Child and Adolescent Psychiatry (AACAP).
The parameters are either patient oriented or clinician ori-
ented. The former are aiming at providing clinicians with
assessment and treatment recommendations for child and
adolescent disorders whereas the latter inform clinicians
about principles of the assessment of children, adolescents,
and their families, and the management of children and
adolescents with special mental health needs. All these
parameters have been published in the journal of the AA-
CAP and are available via the internet of this association.
So far, there has been undertaken no comparable effort
to design a similar number of child and adolescent psy-
chiatric guidelines in any other part of the world. European
efforts have pertained to the design of a few guidelines
addressing hyperkinetic disorders/ADHD, anorexia nerv-
osa, depression, and tic disorders. All these guidelines have
been published in this journal, but, due to the lack of ini-
tiatives by a central coordinating professional association,
are not available on the internet. In addition, national child
and adolescent psychiatric guidelines have been produced
in various countries.
Clinical guidelines should unfold a strong impact on
clinical practice if they are reflected and implemented in
practice. Currently, it is not well studied to which extent
clinicians actually adhere to guidelines. A first step for their
implementation is sufficient information and advice.
Accordingly, each chapter of the present supplement
introduces the most relevant guidelines for assessment and
treatment of the various child and adolescent psychiatric
disorders and provides some suggestions how the guideline
recommendations may be successfully implemented into
clinical care. However, it should also be clear that guide-
lines need to be adjusted to the needs of the individual
patient. Whereas on the one hand there should be no room
for ignorance and uncritical beliefs in clinical practice, there
should also be a place left for clinical expertise and wisdom
that may not be adequately covered by any guideline.
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